NCT00492037

Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

A 5-Day, Double-Blind, Placebo-Controlled Multicenter Study of Oral YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 83 (actual)
• Sponsor: Cumberland Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Study of efficacy \& safety of oral YM087 in subjects with euvolemic or hypervolemic hyponatremia

Conditions

• Hyponatremia

Interventions

Type	Name	Description
DRUG	YM087 oral

Timeline

• Start date: 2000-01-01
• Completion: 2002-02-01
• First posted: 2007-06-27
• Last updated: 2014-05-02

Locations

29 sites across 9 countries: Belgium, Finland, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom